You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
1 May 2026 - Australian pharmaceutical company Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) announced on Thursday that the marketing authorisation application (MAA) filed in Europe for TLX101-Px (O-(2-[18F] fluoroethyl)-L-tyrosine, 18F-FET),...
1 May 2026 - FDB (First Databank Inc), a provider of workflow-integrated drug knowledge for healthcare professionals, announced on Thursday the launch of its new gravimetric module, designed to help pharmacies improve the safety, accuracy, and effici...
1 May 2026 - Bioregenerative technology company FesariusTherapeutics Inc announced on Thursday the publication of its peer reviewed evidence of category leading speed of 'neodermis' formation, which it claims may have the potential to reduc...
30 April 2026 - Cell therapy company Curocell (KOSDAQ:372320) announced on Thursday that RIMQARTO Inj. (anbalcabtagene autoleucel) has received full regulatory approval from South Korea's Ministry of Food and Drug Safety, marking the first comme...
29 April 2026 - Biopharmaceutical company HUTCHMED (China) Limited (Nasdaq:HCM) (AIM:HCM) (HKEX:13) announced on Wednesday that the New Drug Application for sovleplenib has been accepted for review and granted priority status by the China National Me...
29 April 2026 - China-based biopharmaceutical company Shanghai Henlius Biotech Inc (HK:2696) and US healthcare company Organon (NYSE:OGN) announced on Wednesday that the European Commission has approved POHERDY (pertuzumab), the first biosimilar to P...
29 April 2026 - Clinical-stage pharmaceutical company Cirius Therapeutics Incannounced on Tuesday a planning grant from the Gates Foundation to advance the development of CIR-0602K as a potential postpartum therapeutic for women with a history of ges...